In recent months, various public health measures have been implemented throughout the world in response to the coronavirus disease 2019 (COVID-19) pandemic. This outbreak, and the subsequent containment policies, may have a range of potential short- and long-term impacts on the monitoring and surveillance of other conditions, such as birth defects. In this commentary, we provide a perspective on these potential impacts on birth defects surveillance and analysis.
We discuss possible effects on clinical birth defect diagnoses, routine birth defects surveillance system activities, and epidemiologic considerations, as well as opportunities for mitigating the impact of COVID-19. Like many other sectors of public health and medicine, birth defects surveillance programs may be faced with organizational and methodological obstacles in the wake of a changing landscape.
VX-661 |
A2664-10 |
ApexBio |
10 mg |
EUR 224.00 |
Description: VX-661, one of vertex derivatives, corrects F508del-CFTR trafficking and increases F508del-CFTR protein activity in vitro [1]. VX-661 treated alone or in combination with ivacaftor have shown to enhance F508del-CFTR traf?cking to the cell surface. VX-661 has been at phase 2 study [1]. |
VX-661 |
A2664-5 |
ApexBio |
5 mg |
EUR 166.00 |
Description: VX-661, one of vertex derivatives, corrects F508del-CFTR trafficking and increases F508del-CFTR protein activity in vitro [1]. VX-661 treated alone or in combination with ivacaftor have shown to enhance F508del-CFTR traf?cking to the cell surface. VX-661 has been at phase 2 study [1]. |
VX-661 |
A2664-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 183.00 |
Description: VX-661, one of vertex derivatives, corrects F508del-CFTR trafficking and increases F508del-CFTR protein activity in vitro [1]. VX-661 treated alone or in combination with ivacaftor have shown to enhance F508del-CFTR traf?cking to the cell surface. VX-661 has been at phase 2 study [1]. |
VX-661 |
A2664-50 |
ApexBio |
50 mg |
EUR 560.00 |
Description: VX-661, one of vertex derivatives, corrects F508del-CFTR trafficking and increases F508del-CFTR protein activity in vitro [1]. VX-661 treated alone or in combination with ivacaftor have shown to enhance F508del-CFTR traf?cking to the cell surface. VX-661 has been at phase 2 study [1]. |
miRZip-661 anti-miR-661 microRNA construct |
MZIP661-PA-1 |
SBI |
Bacterial Streak |
EUR 684.00 |
|
hsa-miR-661 Primers |
MPH01964 |
ABM |
150 ul / 10 uM |
EUR 121.00 |
p24-HIV(p24/661) Antibody |
BNUB0661-100 |
Biotium |
100uL |
EUR 209.00 |
Description: Primary antibody against p24-HIV(p24/661), Concentration: 0.2mg/mL |
p24-HIV(p24/661) Antibody |
BNUB0661-500 |
Biotium |
500uL |
EUR 458.00 |
Description: Primary antibody against p24-HIV(p24/661), Concentration: 0.2mg/mL |
p24-HIV(p24/661) Antibody |
BNUM0661-50 |
Biotium |
50uL |
EUR 395.00 |
Description: Primary antibody against p24-HIV(p24/661), 1mg/mL |
p24-HIV(p24/661) Antibody |
BNC040661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC040661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC550661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF555 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC550661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF555 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC610661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF660R conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC610661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF660R conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC470661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF647 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC470661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF647 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC050661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC050661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC400661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC400661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC430661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF543 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC430661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF543 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC800661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC800661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCP0661-250 |
Biotium |
250uL |
EUR 383.00 |
Description: Primary antibody against p24-HIV(p24/661), PerCP conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCR0661-250 |
Biotium |
250uL |
EUR 383.00 |
Description: Primary antibody against p24-HIV(p24/661), RPE conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCA0661-250 |
Biotium |
250uL |
EUR 383.00 |
Description: Primary antibody against p24-HIV(p24/661), APC conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCAP0661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCAP0661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCB0661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCB0661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCH0661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNCH0661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC940661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC940661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC680661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF568 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC680661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF568 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC700661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC700661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC880661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC880661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC810661-100 |
Biotium |
100uL |
EUR 199.00 |
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL |
p24-HIV(p24/661) Antibody |
BNC810661-500 |
Biotium |
500uL |
EUR 544.00 |
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL |
hsa-miR-661 miRNA Inhibitor |
MIH03370 |
ABM |
2 x 5.0 nmol |
EUR 176.00 |
hsa-miR-661 miRNA Antagomir |
MNH03370 |
ABM |
2 x 5.0 nmol |
EUR 329.00 |
Recombinant (E.Coli) Protein Kinase A Inactive holoenzyme type 1 alpha |
RP-661 |
Alpha Diagnostics |
1 ug |
EUR 164.00 |
MAP Kinase Substrate; EGF-R (661-681) |
5-01501 |
CHI Scientific |
4 x 1mg |
Ask for price |
Polyclonal MYOM2 / Myomesin 2 Antibody (aa612-661) |
APR03243G |
Leading Biology |
0.05ml |
EUR 484.00 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MYOM2 / Myomesin 2 (aa612-661). This antibody is tested and proven to work in the following applications: |
Human pre-microRNA Expression Construct Lenti-miR-661 |
PMIRH661PA-1 |
SBI |
Bacterial Streak |
EUR 684.00 |
|
Recombinant Pichia pastoris SNX4 Protein (aa 1-661) |
VAng-Cr6678-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Pichia pastoris Sorting nexin-4 (SNX4), recombinant protein. |
Recombinant Clostridium Difficile fbp Protein (aa 1-661) |
VAng-Lsx9156-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Clostridium Difficile (strain 630) Fructose-1,6-bisphosphatase class 3, recombinant protein. |
Recombinant Mycobacterium Tuberculosis Rv0102 Protein (aa 1-661) |
VAng-Yyj0176-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 6731.00 |
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv0102/MT0111 (Rv0102, MT0111), recombinant protein. |
Recombinant Treponema Pallidum tkt Protein (aa 1-661) |
VAng-Cr0963-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Treponema Pallidum (strain Nichols) transketolase (tkt), recombinant protein. |
Recombinant Clostridium Tetani uvrB Protein (aa 1-661) |
VAng-Lsx01835-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Clostridium Tetani UvrABC system protein B, recombinant protein. |
Recombinant Brucella Abortus bhuA Protein (aa 1-661) |
VAng-Lsx5157-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Brucella Abortus biovar 1 (strain 9-941) Heme transporter BhuA, recombinant protein. |
Recombinant Brucella Suis bhuA Protein (aa 1-661) |
VAng-Lsx5721-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Brucella Suis biovar 1 (strain 1330) Heme transporter BhuA, recombinant protein. |
Recombinant HCV-1c E2 Protein (aa 384-661) [His] |
VAng-Wyb7362-100g |
Creative Biolabs |
100 µg |
EUR 1747.00 |
Description: Hepatitis C virus (serotype 1c,isolate HC-G9) E2 protein, recombinant protein. |
Recombinant HCV-1c E2 Protein (aa 384-661) [His] |
VAng-Wyb7362-20g |
Creative Biolabs |
20 µg |
EUR 679.00 |
Description: Hepatitis C virus (serotype 1c,isolate HC-G9) E2 protein, recombinant protein. |
Recombinant HCV-1c E2 Protein (aa 384-661) [His] |
VAng-Wyb7362-50g |
Creative Biolabs |
50 µg |
EUR 1213.00 |
Description: Hepatitis C virus (serotype 1c,isolate HC-G9) E2 protein, recombinant protein. |
Recombinant Trypanosoma Brucei HSP70-4 Protein (aa 1-661) |
VAng-Wyb8104-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Trypanosoma Brucei brucei Heat shock 70 kDa protein 4, partial, recombinant protein. |
Recombinant Caenorhabditis Elegans lst-2 Protein (aa 1-661) |
VAng-Ly3528-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Caenorhabditis Elegans lateral signaling target protein 2 (lst-2), partial, recombination protein. |
Anti-Hu CD84 Purified |
11-661-C025 |
ExBio |
0.025 mg |
EUR 99.00 |
Anti-Hu CD84 Purified |
11-661-C100 |
ExBio |
0.1 mg |
EUR 158.00 |
Anti-Hu CD84 APC |
1A-661-T025 |
ExBio |
25 tests |
EUR 140.00 |
Anti-Hu CD84 APC |
1A-661-T100 |
ExBio |
100 tests |
EUR 240.00 |
Anti-Hu CD84 FITC |
1F-661-T025 |
ExBio |
25 tests |
EUR 122.00 |
Anti-Hu CD84 FITC |
1F-661-T100 |
ExBio |
100 tests |
EUR 204.00 |
Anti-Hu CD84 PE |
1P-661-T025 |
ExBio |
25 tests |
EUR 140.00 |
Anti-Hu CD84 PE |
1P-661-T100 |
ExBio |
100 tests |
EUR 240.00 |
Anti-Hu CD84 Purified Low Endotoxin |
12-661-C100 |
ExBio |
0.1 mg |
EUR 158.00 |
Anti-AFP (Tacatuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC |
ADC-W-661 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-AFP monoclonal antibody conjugated via a MC-Vc-PAB-DMEA-(PEG2) linker to duocarmycin SA |
HIV type 1 Glycoprotein 140 (aa 37 - 661)(Du151) [His] |
DAG2131 |
Creative Diagnostics |
100 µg |
Ask for price |
Recombinant Brucella Abortus bhuA Protein (strain 2308) (aa 1-661) |
VAng-Lsx4953-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Brucella Abortus (strain 2308) Heme transporter BhuA, recombinant protein. |
MAP Kinase Substrate; EGF-R (661-681) (AA: Lys-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Ala-Leu-Leu-Arg) (MW: 2318.66) |
SP-101475-1 |
Alpha Diagnostics |
1 mg |
EUR 164.00 |
A better understanding of these potential challenges faced by birth defects surveillance programs could facilitate better planning and collaboration across programs to overcome barriers to core activities and to prepare for novel opportunities for research and prevention.